SEARCH

SEARCH BY CITATION

References

  • Amin V., Cumming D. V., Coffin R. S. and Latchman D. S. (1995) The degree of protection provided to neuronal cells by a pre-conditioning stress correlates with the amount of heat shock protein 70 it induces and not with the similarity of the subsequent stress. Neurosci. Lett. 200, 8588.
  • Beere H. M., Wolf B. B., Cain K., Mosser D. D., Mahboubi A., Kuwana T., Tailor P., Morimoto R. I., Cohen G. M. and Green D. R. (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2, 469475.
  • Creagh E. M., Carmody R. J. and Cotter T. G. (2000) Heat shock protein 70 inhibits caspase-dependent and -independent apoptosis in Jurkat T cells. Exp. Cell Res. 257, 5866.
  • Dehmer T., Heneka M. T., Sastre M., Dichgans J. and Schulz J. B. (2004) Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J. Neurochem. 88, 494501.
  • Diem R., Taheri N., Dietz G. P., Kuhnert A., Maier K., Sa̋ttler M. B., Gadjanski I., Merkler D. and Ba̋hr M. (2005) HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis. Neorobiol Dis. 20, 218226.
  • Dietz G. P. H. and Bähr M. (2004) Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27, 85131.
  • Dietz G. P. H. and Bähr M. (2005) Peptide-enhanced cellular internalization of proteins in neuroscience. Brain Res. Bull. 68, 103114.
  • Dietz G. P. H., Kilic E. and Bähr M. (2002) Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol. Cell. Neurosci. 21, 2937.
  • Dietz G. P. H., Dietz B. and Bähr M. (2006a) Bcl-x(L) increases axonal numbers but not axonal elongation from rat retinal explants. Brain Res. Bull. 70, 117123.
  • Dietz G. P. H., Valbuena P. C., Dietz B., Meuer K., Mueller P., Weishaupt J. H. and Bähr M. (2006b) Application of a blood–brain-barrier-penetrating form of GDNF in a mouse model for Parkinson’s disease. Brain Res. 1082, 6166.
  • Dong Z., Wolfer D. P., Lipp H. P. and Bueler H. (2005) Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. Mol. Ther. 11, 8088.
  • Eberhardt O., Coelln R. V., Kügler S. et al. (2000) Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. J. Neurosci. 20, 91269134.
  • Finn J. T., Weil M., Archer F., Siman R., Srinivasan A. and Raff M. C. (2000) Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20, 13331341.
  • Fornai F., Schluter O. M., Lenzi P. et al. (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl Acad. Sci. USA 102, 34133418.
  • Galazka G., Stasiolek M., Walczak A., Jurewicz A., Zylicz A., Brosnan C. F., Raine C. S. and Selmaj K. W. (2006) Brain-derived heat shock protein 70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis. J. Immunol. 176, 15881599.
  • Garrido C., Gurbuxani S., Ravagnan L. and Kroemer G. (2001) Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 286, 433442.
  • Giffard R. G. and Yenari M. A. (2004) Many mechanisms for Hsp70 protection from cerebral ischemia. J. Neurosurg. Anesthesiol. 16, 5361.
  • Guegan C., Braudeau J., Couriaud C., Dietz G. P., Lacombe P., Bahr M., Nosten-Bertrand M. and Onteniente B. (2006) PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms. Neurobiol. Dis. 22, 177186.
  • Kelly S., Bieneman A., Horsburgh K., Hughes D., Sofroniew M. V., McCulloch J. and Uney J. B. (2001) Targeting expression of Hsp70i to discrete neuronal populations using the Lmo-1 promoter: assessment of the neuroprotective effects of Hsp70i in vivo and in vitro. J. Cereb. Blood Flow Metab. 21, 972981.
  • Kelly S., Zhang Z. J., Zhao H., Xu L., Giffard R. G., Sapolsky R. M., Yenari M. A. and Steinberg G. K. (2002) Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann. Neurol. 52, 160167.
  • Klucken J., Shin Y., Masliah E., Hyman B. T. and McLean P. J. (2004) Hsp70 reduces alpha-synuclein aggregation and toxicity. J. Biol. Chem. 279, 2549725502.
  • Lai Y., Du L., Dunsmore K. E., Jenkins L. W., Wong H. R. and Clark R. S. (2005) Selectively increasing inducible heat shock protein 70 via TAT-protein transduction protects neurons from nitrosative stress and excitotoxicity. J. Neurochem. 94, 360366.
  • Linder J. C., Klemfuss H. and Groves P. M. (1987) Acute ultrastructural and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Neurosci. Lett. 82, 221226.
  • Lingor P., Unsicker K. and Krieglstein K. (2000) GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide. Exp. Neurol. 163, 5562.
  • Mayer R. A., Kindt M. V. and Heikkila R. E. (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J. Neurochem. 47, 10731079.
  • Mosser D. D., Caron A. W., Bourget L., Denis-Larose C. and Massie B. (1997) Role of the human heat shock protein Hsp70 in protection against stress-induced apoptosis. Mol. Cell. Biol. 17, 53175327.
  • Przedborski S., Tieu K., Perier C. and Vila M. (2004) MPTP as a mitochondrial neurotoxic model of Parkinson’s disease. J. Bioenerg. Biomembr. 36, 375379.
  • Quigney D. J., Gorman A. M. and Samali A. (2003) Heat shock protects PC12 cells against MPP+ toxicity. Brain Res. 993, 133139.
  • Ransom B. R., Kunis D. M., Irwin I. and Langston J. W. (1987) Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Neurosci. Lett. 75, 323328.
  • Ravagnan L., Gurbuxani S., Susin S. A. et al. (2001) Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3, 839843.
  • Richard J. P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M. J., Chernomordik L. V. and Lebleu B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585590; Epub October 30, 2002.
  • Rossetti Z. L., Sotgiu A., Sharp D. E., Hadjiconstantinou M. and Neff N. H. (1988) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. Biochem. Pharmacol. 37, 45734574.
  • Saleh A., Srinivasula S. M., Balkir L., Robbins P. D. and Alnemri E. S. (2000) Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2, 476483.
  • Schulz J. B. and Beal M. F. (1994) Mitochondrial dysfunction in movement disorders. Curr. Opin. Neurol. 7, 333339.
  • Schulz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. W., Rosen B. R. and Beal M. F. (1995) Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64, 22392247.
  • Schutze-Redelmeier M. P., Gournier H., Garcia-Pons F., Moussa M., Joliot A. H., Volovitch M., Prochiantz A. and Lemonnier F. A. (1996) Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J. Immunol. 157, 650655.
  • Schwarze S. R., Ho A., Vocero-Akbani A. and Dowdy S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 15691572.
  • Shen H. Y., He J. C., Wang Y., Huang Q. Y. and Chen J. F. (2005) Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice. J. Biol. Chem. 280, 3996239969.
  • Shimoji M., Zhang L., Mandir A. S., Dawson V. L. and Dawson T. M. (2005) Absence of inclusion body formation in the MPTP mouse model of Parkinson’s disease. Brain Res. Mol. Brain Res. 134, 103108.
  • Soane L. and Fiskum G. (2005) TAT-mediated endocytotic delivery of the loop deletion Bcl-2 protein protects neurons against cell death. J. Neurochem. 95, 230243.
  • Song D. D., Shults C. W., Sisk A., Rockenstein E. and Masliah E. (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186, 158172.
  • Susin S. A., Lorenzo H. K., Zamzami N. et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441446.
  • Tatton N. A. and Kish S. J. (1996) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77, 10371048.
  • Tipton K. F. and Singer T. P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61, 11911206.
  • Wheeler D. S., Dunsmore K. E. and Wong H. R. (2003) Intracellular delivery of HSP70 using HIV-1 Tat protein transduction domain. Biochem. Biophys. Res. Commun. 301, 5459.
  • Wong H. R., Mannix R. J., Rusnak J. M., Boota A., Zar H., Watkins S. C., Lazo J. S. and Pitt B. R. (1996) The heat-shock response attenuates lipopolysaccharide-mediated apoptosis in cultured sheep pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 15, 745751.
  • Yenari M. A., Fink S. L., Sun G. H., Chang L. K., Patel M. K., Kunis D. M., Onley D., Ho D. Y., Sapolsky R. M. and Steinberg G. K. (1998) Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann. Neurol. 44, 584591.
  • Yenari M. A., Liu J., Zheng Z., Vexler Z. S., Lee J. E. and Giffard R. G. (2005) Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann. NY Acad. Sci. 1053, 7483.
  • Yin W., Cao G., Johnnides M. J., Signore A. P., Luo Y., Hickey R. W. and Chen J.(2006) TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol. Dis. 21, 358371; Epub September 6, 2005.